Adverse Drug Reaction Classification System
Drug ID |
Drug Name
|
CAS RN
|
Molecular Formula
|
Structure
|
BADD_D02491 | Valbenazine | 1025504-45-3 | C24H38N2O4 | |
BADD_D02492 | Deflazacort | 14484-47-0 | C25H31NO6 | |
BADD_D02493 | Selinexor | 1393477-72-9 | C17H11F6N7O | |
BADD_D02494 | Delafloxacin | 189279-58-1 | C18H12ClF3N4O4 | |
BADD_D02495 | Duvelisib | 1201438-56-3 | C22H17ClN6O | |
BADD_D02496 | Elagolix | 834153-87-6 | C32H30F5N3O5 | |
BADD_D02497 | Avatrombopag | 570406-98-3 | C29H34Cl2N6O3S2 | |
BADD_D02498 | Abemaciclib | 1231929-97-7 | C27H32F2N8 | |
BADD_D02499 | Fostamatinib | 901119-35-5 | C23H26FN6O9P | |
BADD_D02500 | Alpelisib | 1217486-61-7 | C19H22F3N5O2S | |
BADD_D02501 | Sarecycline | 1035654-66-0 | C24H29N3O8 | |
BADD_D02502 | Letermovir | 917389-32-3 | C29H28F4N4O4 | |
BADD_D02503 | Telotristat ethyl | 1033805-22-9 | C27H26ClF3N6O3 | |
BADD_D02504 | Lorlatinib | 1454846-35-5 | C21H19FN6O2 | |
BADD_D02505 | Gilteritinib | 1254053-43-4 | C29H44N8O3 | |
BADD_D02506 | Erdafitinib | 1346242-81-6 | C25H30N6O2 | |
BADD_D02507 | Deutetrabenazine | 1392826-25-3 | C19H27NO3 | |
BADD_D02508 | Edaravone | 89-25-8 | C10H10N2O | |
BADD_D02509 | Brigatinib | 1197953-54-0 | C29H39ClN7O2P | |
BADD_D02510 | Rucaparib | 283173-50-2 | C19H18FN3O | |
BADD_D02511 | Siponimod | 1230487-00-9 | C29H35F3N2O3 | |
BADD_D02512 | Secnidazole | 3366-95-8 | C7H11N3O3 | |
BADD_D02513 | Pegvaliase | 1585984-95-7 | C15H30N2O5 | |
BADD_D02514 | Etelcalcetide | 1262780-97-1 | C38H73N21O10S2 | |
BADD_D02515 | Pexidartinib | 1029044-16-3 | C20H15ClF3N5 | |
BADD_D02516 | Plecanatide | 467426-54-6 | C65H104N18O26S4 | |
BADD_D02517 | Enasidenib | 1446502-11-9 | C19H17F6N7O | |
BADD_D02518 | Semaglutide | 910463-68-2 | C187H291N45O59 | |
BADD_D02519 | Netarsudil | 1254032-66-0 | C28H27N3O3 | |
BADD_D02520 | Baloxavir marboxil | 1985606-14-1 | C27H23F2N3O7S | |